1. Home
  2. BTU vs IRON Comparison

BTU vs IRON Comparison

Compare BTU & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peabody Energy Corporation

BTU

Peabody Energy Corporation

HOLD

Current Price

$25.22

Market Cap

2.7B

Sector

Energy

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.76

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTU
IRON
Founded
2016
2017
Country
United States
United States
Employees
6600
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
BTU
IRON
Price
$25.22
$68.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$32.83
$103.18
AVG Volume (30 Days)
2.1M
463.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,861,500,000.00
N/A
Revenue This Year
$17.96
N/A
Revenue Next Year
$5.47
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.06
$40.00
52 Week High
$41.14
$99.50

Technical Indicators

Market Signals
Indicator
BTU
IRON
Relative Strength Index (RSI) 41.63 30.34
Support Level $25.20 $64.48
Resistance Level $31.88 $71.85
Average True Range (ATR) 1.20 3.16
MACD -0.48 -1.20
Stochastic Oscillator 1.81 12.42

Price Performance

Historical Comparison
BTU
IRON

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: